Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cardiol Therapeutics Inc
(TSX:
CRDL
)
2.610
+0.030 (+1.16%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
54,800
Open
2.580
Bid (Size)
2.610 (10)
Ask (Size)
2.630 (1)
Prev. Close
2.580
Today's Range
2.540 - 2.630
52wk Range
0.9100 - 4.260
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
June 17, 2024
In a phenomenal year marked by over +180% gains in its stock price, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) added another feather to its cap last week with the announcement of its Phase II...
Via
TheNewswire.com
Exposures
Product Safety
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
June 17, 2024
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
Via
News Direct
Exposures
Product Safety
Performance
YTD
+119.33%
+119.33%
1 Month
-10.00%
-10.00%
3 Month
-31.50%
-31.50%
6 Month
+8.75%
+8.75%
1 Year
+93.33%
+93.33%
More News
Read More
Cardiol Therapeutics Announces Positive Topline Data from its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
June 13, 2024
Via
Newsfile
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Via
AB Newswire
Topics
ETFs
Exposures
Product Safety
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Via
TheNewswire.com
Topics
ETFs
Exposures
Product Safety
Analysts Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL)
May 28, 2024
Via
AB Newswire
Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics
May 28, 2024
Via
News Direct
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
February 21, 2024
Via
Newsfile
Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
February 15, 2024
Via
Newsfile
Exposures
Product Safety
Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis
November 01, 2023
Via
Newsfile
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
October 10, 2023
Via
Benzinga
Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction
October 10, 2023
Via
Newsfile
Cardiol Therapeutics On Track To Provide New Standard Of Care For Cardiovascular Diseases ($CRDL)
October 10, 2023
Via
AB Newswire
Topics
Stocks
Exposures
US Equities
Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
October 02, 2023
Via
AB Newswire
Topics
Death
Exposures
Death
Product Safety
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
September 19, 2023
Via
Newsfile
Cardiol Therapeutics Announces Poster Presentation at The Annual Scientific Meeting of the Heart Failure Society of America
September 28, 2022
Via
Newsfile
Hot Debate Over Myocarditis Risk Shines Spotlight on Heart Disease
July 26, 2022
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Via
FinancialNewsMedia
Topics
Climate Change
Emissions
Energy
Exposures
Climate
Fossil Fuels
The Healthcare Companies Fighting the World’s Biggest Killers
July 13, 2022
Via
FinancialNewsMedia
Tackling Recurring Health Conditions Offers Hope to Patients
June 21, 2022
Via
FinancialNewsMedia
As Health Problems Mount Patients Welcome New Treatments
June 14, 2022
Via
FinancialNewsMedia
Breakthroughs In Treating Killer Diseases Could Lengthen Life
June 07, 2022
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Market Movers. Today’s Top Stock Picks For New & Trending Opportunities
May 27, 2022
From
Stockhouse Publishing
Via
AccessWire
Why Orphan Drug Designation Offers Several Benefits
May 18, 2022
Via
FinancialNewsMedia
Exposures
Product Safety
Heart Failure Treatment Offers Hope to Diabetics
May 11, 2022
Via
FinancialNewsMedia
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.